The 119th Congress is in full swing, and one priority should be reforming the U.S. Patent and Trademark Office's (USPTO) quasi-judicial patent review board.

Opinion: Fish attorneys say that changes at the US Patent and Trademark Office and broader regulatory moves could increase ...

Senate passes a bill that would prevent pharma firms from building patent thickets to delay biosimilar competitors to biologics.

For generations, the U.S. patent system has driven breakthrough innovations from the telegraph to mRNA vaccines. PTAB reform ...

Opinion: Retired federal appeals court judges Paul Michel and Kathleen O'Malley say Congress should pass legislation to ...

The Senate Armed Services Committee’s version of the fiscal 2026 defense policy bill, expected to be released later today, will incorporate sweeping acquisition reforms drawn from a separate bill ...

The United States is falling behind in the global race for technological leadership. China now leads the U.S. in 37 out of 44 critical technologies. This includes fields that will define the future, ...

The United States is falling behind in the global race for technological leadership. China now leads the U.S. in 37 out of 44 critical technologies.

The US Patent and Trademark Office (USPTO) has finalized a rule increasing the annual limit on accepted requests for ...

Iowa enacted Senate File 383 (the Act), a comprehensive bill aimed at regulating pharmacy benefit managers (PBMs) with the ...

Providing news, analysis, and insights on the Washington, D.C. legal community, including in-depth coverage of SCOTUS, appellate courts, and key regulatory bodies.

Pharmaceutical Research & Manufacturers of America organization profile: annual lobbying totals since 1998, and bills lobbied in 2024.